What is it about?
This chapter is about using medicinal plants and their natural compounds to protect the brain and nervous system, particularly against neurodegenerative diseases. The chapter is by Lenin Kumar Bompalli and appears in Springer’s 2025 book Medicinal Plants and Their Bioactives in Human Diseases, covering pages 475–483. The central question is: Can compounds from medicinal plants be developed into effective treatments that protect brain cells from damage? It focuses on diseases such as: Alzheimer’s disease Parkinson’s disease Huntington’s disease Other conditions involving - neuronal damage and degeneration What does “neuroprotective phytomedicine” mean? Neuroprotective = protecting nerve cells/neurons from damage. Phyto = plant. Medicine = a substance used for prevention or treatment. So, neuroprotective phytomedicines are plant-derived medicines or bioactive compounds that may protect neurons and support brain health. The chapter discusses compounds such as curcumin, resveratrol, and Ginkgo biloba extracts, which have been investigated for antioxidant, anti-inflammatory, and other neuroprotective effects. Why is it important? The major challenge is that showing a beneficial effect in laboratory or animal studies is not the same as developing a proven medicine for humans. The chapter highlights several barriers: 1. Oxidative stress Plant compounds may help counter molecules that damage neurons. 2. Neuroinflammation Some phytochemicals may reduce harmful inflammation in nervous tissue. 3. Neuronal cell death Certain compounds may interfere with pathways involved in apoptosis and neuronal damage. 4. Poor bioavailability Some promising plant compounds are poorly absorbed or rapidly metabolized, so insufficient amounts may reach the brain. 5. Standardization Plant extracts can vary depending on the plant variety, growing conditions, extraction method, and composition. This makes it difficult to guarantee the same dose and effect every time. 6. Blood–brain barrier A major challenge is getting a therapeutic compound from the bloodstream into the brain. 7. Clinical evidence and regulation A compound needs strong evidence for safety, dosage, pharmacokinetics, and efficacy in humans** before it can become an established therapeutic product. What are the future prospects? The chapter points toward approaches such as: Advanced extraction techniques Nanotechnology-based formulations Targeted drug-delivery systems Better standardization of plant extracts Rigorous clinical trials Investigation of pharmacokinetics, safety, and efficacy
Featured Image
Photo by Markus Kammermann on Unsplash
Why is it important?
It is important because neurodegenerative diseases such as Alzheimer’s and Parkinson’s are difficult to treat, and existing treatments often manage symptoms rather than preventing or reversing the underlying damage to nerve cells. The importance of this chapter can be understood in five points: 1. Protecting brain cells It explores whether compounds from medicinal plants can help protect neurons from oxidative stress, inflammation, and cell damage. 2. Finding new therapeutic options Plants contain many biologically active compounds that could provide new candidates for developing neuroprotective medicines. 3. Addressing limitations of current treatments Neurodegenerative diseases are complex, so researchers are looking for approaches that target multiple mechanisms involved in neuronal damage. 4. Identifying the challenges A plant compound may look promising in laboratory studies but still fail as a medicine because of poor absorption, low bioavailability, difficulty crossing the blood–brain barrier, toxicity, or lack of clinical evidence. 5. Connecting traditional medicine with modern drug development Studying phytochemicals scientifically can help identify which traditional medicinal plants have genuine therapeutic potential and how their active compounds could be developed into standardized, safe, evidence-based treatments. This research is important because it looks for natural compounds that may help protect the brain from damage and explores how these compounds could eventually be developed into safe and effective treatments for neurological diseases. This research explores how natural compounds from medicinal plants may help protect brain cells and contribute to future treatments for diseases such as Alzheimer’s and Parkinson’s.
Perspectives
The future of neuroprotective phytomedicines is promising, but more scientific evidence is needed before plant-derived compounds can become reliable treatments. The chapter particularly points toward improving delivery, bioavailability, standardization, and clinical validation. Key future directions include: Discovering new plant compounds with neuroprotective properties. Improving brain delivery so active compounds can reach the nervous system effectively. Using nanotechnology and targeted delivery systems to improve the bioavailability of poorly absorbed phytochemicals. Standardizing plant extracts so their composition and therapeutic effects are consistent. Developing combination therapies that target several mechanisms involved in neurodegeneration. Conducting well-designed clinical trials to establish safety, appropriate dosage, pharmacokinetics, and actual effectiveness in humans. Strengthening quality control and regulatory frameworks before these products can be widely used as medicines.
Dr. Lenin Kumar Bompalli
Dr. B. R. Ambedkar University, Etcherla.
Read the Original
This page is a summary of: Prospects and Challenges in Developing Neuroprotective Phytomedicines, January 2025, Springer Science + Business Media,
DOI: 10.1007/978-3-032-01356-9_20.
You can read the full text:
Contributors
The following have contributed to this page







